Scott Gottlieb gave a savvy review of what we can expect at the FDA; When times got rough, a biotech CEO demonstrated real integrity
Smart, reasonable and extremely well prepared: What did we learn from Scott Gottlieb’s confirmation hearing?
On Wednesday, when Scott Gottlieb showed up for his confirmation hearing at the Senate, it became quickly apparent that the prospective FDA commissioner was the best prepared person talking that day. What the Dems had billed as a sharp attack on Gottlieb’s industry ties quickly disintegrated into a series of random, disjointed comments directed against largely unrelated issues.
This article is for premium subscribers only
Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.